Nurexone Biologic Inc
F:J90
Nurexone Biologic Inc
F:J90
Price:
0.341
EUR
-10.26%
Market Closed
Market Cap:
€22.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nurexone Biologic Inc
F:J90
|
CA |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
A
|
Absa Bank Ltd
JSE:ABSP
|
ZA |
|
Marriott International Inc
NASDAQ:MAR
|
US |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
Aurora Innovation Inc
NASDAQ:AUR
|
US |
|
HomeServe PLC
LSE:HSV
|
UK |
|
Reliance Global Group Inc
NASDAQ:RELI
|
US |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
Copernico SIM SpA
MIL:COP
|
IT |
|
Rio Tinto PLC
LSE:RIO
|
UK |
|
Deckers Outdoor Corp
NYSE:DECK
|
US |
Wall St Price Targets
J90 Price Targets Summary
Nurexone Biologic Inc
Nurexone Biologic Inc
Wall Street analysts forecast J90 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for J90 is 2.403 EUR with a low forecast of 2.38 EUR and a high forecast of 2.474 EUR.
Lowest Forecast
Price Target
2.38
EUR
598% Upside
Average Forecast
Price Target
2.403
EUR
605% Upside
Highest Forecast
Price Target
2.474
EUR
625% Upside
Nurexone Biologic Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is J90's stock price target?
Price Target
2.403
EUR
2.403
EUR
According to Wall Street analysts, the average 1-year price target for J90 is 2.403 EUR with a low forecast of 2.38 EUR and a high forecast of 2.474 EUR.
